HOOKIPA Pharma (NASDAQ:HOOK) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.53) by 1.89 percent. This is a 85.71 percent decrease over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $5.38 million which beat the analyst consensus estimate of $5.13 million by 4.83 percent. This is a 19.55 percent decrease over sales of $6.68 million the same period last year.
HOOKIPA Pharma Q2 EPS $(0.52) Beats $(0.53) Estimate, Sales $5.38M Beat $5.13M Estimate
HOOKIPA Pharma (NASDAQ:HOOK) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.53) by 1.89 percent. This is a 85.71 percent decrease over losses of $(0.28) per share from the
